| Financial Year |
March 31 2023 |
| Monetary Funds |
3,181,977,916.57 |
| Held-for-trading Financial Assets |
270,743,632.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,585,638,190.62 |
| Advances to Suppliers |
742,575,294.52 |
| Other Receivables |
351,101,672.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,610,373.44 |
| Dividend Receivable |
-- |
| Inventories |
1,795,377,795.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
175,289,178.01 |
| Total Current Assets |
10,316,951,873.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,375,522.68 |
| Long-term Equity Investment |
541,532,058.95 |
| Investment Properties |
378,241,310.78 |
| Fixed Assetes |
1,878,590,035.51 |
| Under-construction Projects |
1,234,822,289.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,113,695,226.86 |
| R&D expenses |
-- |
| Goodwill |
86,126,754.23 |
| Long-Term Deferred and Prepaid Expenses |
4,495,956.54 |
| Deferred Income Tax Assets |
924,024,137.13 |
| Other Non-Current Assets |
68,004,262.46 |
| Sub-Total of Non-Current Assets |
9,395,537,653.14 |
| Total Assets |
19,712,489,526.38 |
| Short-Term Loans |
4,279,587,932.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,473,279.95 |
| Accounts Payable |
1,290,781,020.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
351,338,929.15 |
| Taxes Payable |
194,843,060.82 |
| Interest Payable |
-- |
| Dividend Payable |
1,821,721.37 |
| Other payables |
408,082,782.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
694,419,241.17 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
9,236,406,028.72 |
| Long-term Loans |
1,351,568,969.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,982,656.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,577,538.49 |
| Deferred Income Tax Liabilities |
804,987,199.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,275,607,632.12 |
| Total Liabilities |
11,512,013,660.84 |
| Paid-In Capital(Or Share Stock) |
1,969,378,424.00 |
| Capital Surplus |
954,358,718.11 |
| Surplus Reserve |
391,194,179.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,004,175,332.36 |
| Minority Stockholder's Interest |
3,304,052,163.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,896,423,702.53 |
| Owner's Equity（Stockholder's Equity） |
8,200,475,865.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,712,489,526.38 |
